Low effectiveness undermines promotion of seasonal influenza vaccine

The Lancet Infectious Diseases

Volumn 13, Issue 1, 2013, Pages 7-9

  Nicoll, Angus ^a   Sprenger, Marc ^a  

^a EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

DRUG EFFICACY; FINANCIAL MANAGEMENT; HUMAN; INFLUENZA VACCINATION; INFLUENZA VIRUS A H3N2; LETTER; PRIORITY JOURNAL; SEASONAL INFLUENZA;

HUMANS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; PATIENT ACCEPTANCE OF HEALTH CARE; TREATMENT OUTCOME;

EID: 84871087046     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(12)70313-4     Document Type: Letter

References (14)

1. Osterholm MT, Kelley NS, Sommer A, et al. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012, 12:36-44.
2. Last JM Dictionary of epidemiology 2001, Oxford University Press, Oxford. 4th edn.
3. Committee for Proprietary Medicinal Products (CPMP). Note for guidance on harmonisation of requirements for influenza vaccines The European Agency for the Evaluation of Medicinal Products, (accessed Dec 2, 2012). http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003945.pdf.
4. Valenciano M, Ciancio BC I-MOVE: a European network to measure the effectiveness of influenza vaccines. Euro Surveill 2012, 17. on behalf of the I-MOVE study team, pii=20281.
5. Kissling E, Valenciano M Early estimates of seasonal influenza vaccine effectiveness in Europe among target groups for vaccination: results from the I-MOVE multicentre case-control study, 2011/12. Euro Surveil 2012, 17. for the I-MOVE Case-Control Studies Team, pii=20146.
6. Kissling E Measuring influenza VE in EU: results 2011-12 and the future. ECDC and WHO EURO annual influenza meeting; Warsaw; May 30, 2012-June 1, 2012 (accessed Dec 2, 2012). http://www.ecdc.europa.eu/en/press/events/Documents/ECDC-WHO-influenza-meeting-Kissling.pdf.
7. Recommended composition of influenza virus vaccines for use in the 201-2013 northern hemisphere influenza season. Word Health Organization WHO, (accessed Dec 2, 2012). http://www.who.int/influenza/vaccines/virus/recommendations/201202_recommendation.pdf.
8. Nicoll A, Ammon A, Amato Gauci A, et al. Experience and lessons from surveillance and studies of the 2009 pandemic in Europe. Public Health 2010, 124:14-23.
9. Council recommendation of 22 December 2009 on seasonal influenza vaccination. (Text with EEA relevance)(2009/1019/EU) Council of the European Union, (accessed Dec 2, 2012). http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2009:348:0071:0072:EN:PDF.
10. Mereckiene J, Cotter S, D'Ancona FD, et al. Differences in national influenza vaccination policies across the European Union, Norway and Iceland 2008-2009. Euro Surveil 2010, 1. for the VENICE project gatekeepers group, pii=19700.
11. O'Flanagan D Seasonal influenza vaccination in Europe: vaccination policy and vaccination coverage. Summary of VENICE surveys. ECDC and WHO EURO annual influenza meeting; Warsaw; May 30, 2012-June 1, 2012 (accessed Dec 2, 2012). http://ecdc.europa.eu/en/press/events/Documents/ECDC-WHO-influenza-meeting-OFlanagan.pdf.
12. Sprenger M Influenza vaccines from a public health perspective: Where are we today? (accessed Dec 2, 2012). http://ecdc.europa.eu/en/aboutus/organisation/Director%20Speeches/ECDC-Director--Seasonal-Influenza-IVW-2012Oct10.pdf.
13. Osterholm M, Kelley N, Manske J, Ballering K, Leighton T, Moore K The compelling need foregame changing influenzasvaccines: an analysis of the InfluenzaVvaccine enterprise and recommendations for the future (accessed Dec 2, 2012). http://www.cidrap.umn.edu/cidrap/files/80/ccivi%20report.pdf.
14. Committee for Medicinal Products for Human Use (CHMP). Concept paper on the revision of guidelines for influenza vaccines European Medicines Agency, (accessed Dec 2, 2012). http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/10/WC500115612.pdf.